The company is called Neocutis. (H/T Gateway Pundit via ECM)
Screen grab from their web site:
Neocutis’ key ingredient known as “Processed Skin Proteins” was developed at the University of Luasanne from the skin tissue of a 14-week gestation electively-aborted male baby donated by the University Hospital in Switzerland. Subsequently, a working cell bank was established, containing several billion cultured skin cells to produce the human growth factor needed to restore aging skin.
I’m sure that child wanted to live.
